Michalski Huettermann and Partner
- Research works
- 51 ▼ 54% vs 2013–17
- Citations
- 270 5.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 30% world 28%
Not ranked overall: Michalski Huettermann and Partner is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 8.4×. Every wedge is a field page.
Which keywords describe research at Michalski Huettermann and Partner?
By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Innovation, Emerging Markets, Entrepreneurship, Medical Ethics, Patient Rights, Genome Engineering and RNA-Guided.
- Coaching
- Party Competition
- Data Protection
- Governance
- Chronic Diseases
- Patient Safety
- Chimeric Antigen Receptor
- Clinical Trials
- Health Biotechnology
- Public Health
- Bottom of the Pyramid
- Ethical Issues
- Therapeutic Antibodies
- Bioanalytical Methods
- Intellectual Property Rights
- Immunogenicity
- RNA-Guided
- Patient Rights
- Entrepreneurship
- Monoclonal Antibodies
- Innovation
- Emerging Markets
- Medical Ethics
- Genome Engineering
- Biopharmaceuticals
- Glycosylation
- Patent Analysis
- Biosimilars
- Antibody Engineering
- Fc Receptors
- Frugal Innovation
- Global Collaboration
- Regulatory Challenges
- CAR T Cells
- Human Rights
- Stem Cell Regulation
- Corporate Governance
- Vaccine
- Legal Methodology
- Bildungsungleichheit
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Innovation6▲ 13×4 topics
- Monoclonal Antibodies6▲ 83×3 topics
- Emerging Markets4▲ 169×2 topics
- Entrepreneurship4▲ 31×2 topics
- Medical Ethics4▲ 40×1 topic
- Patient Rights4▲ 72×1 topic
- Genome Engineering4▲ 117×1 topic
- RNA-Guided4▲ 117×1 topic
- Biopharmaceuticals3▲ 93×2 topics
- Immunogenicity3▲ 124×2 topics
- Glycosylation3▲ 28×2 topics
- Intellectual Property Rights3▲ 133×1 topic
- Patent Analysis3▲ 361×1 topic
- Bioanalytical Methods3▲ 403×1 topic
- Biosimilars3▲ 403×1 topic
- Therapeutic Antibodies3▲ 46×2 topics
- Antibody Engineering3▲ 55×1 topic
- Ethical Issues3▲ 57×4 topics
- Fc Receptors3▲ 55×1 topic
- Bottom of the Pyramid2▲ 140×1 topic
- Frugal Innovation2▲ 140×1 topic
- Public Health2▲ 3.1×4 topics
- Global Collaboration2▲ 100×1 topic
- Health Biotechnology2▲ 216×1 topic
- Regulatory Challenges2▲ 49×2 topics
- Clinical Trials2▲ 5.2×2 topics
- CAR T Cells2▲ 68×1 topic
- Chimeric Antigen Receptor2▲ 68×1 topic
- Human Rights2▲ 3.4×2 topics
- Patient Safety2▲ 24×1 topic
- Stem Cell Regulation2▲ 127×1 topic
- Chronic Diseases1▲ 9.3×2 topics
- Corporate Governance1▲ 4.8×4 topics
- Governance1▲ 8.7×2 topics
- Vaccine1▲ 6.2×2 topics
- Data Protection1▲ 125×2 topics
- Legal Methodology1▲ 80×1 topic
- Party Competition1▲ 147×1 topic
- Bildungsungleichheit1▲ 69×1 topic
- Coaching1▲ 102×1 topic
Which research topics does Michalski Huettermann and Partner publish most on?
By volume in 2022–2025: CRISPR and Genetic Engineering, Innovation and Socioeconomic Development, SARS-CoV-2 and COVID-19 Research and RNA Interference and Gene Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CRISPR and Genetic Engineering Molecular Biology 2 works
- 2 Innovation and Socioeconomic Development Business and International Management 2 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 4 RNA Interference and Gene Delivery Molecular Biology 0 works
- 5 Academic Publishing and Open Access Information Systems and Management 0 works
- 6 COVID-19 Digital Contact Tracing Information Systems 0 works
- 7 Genetics, Aging, and Longevity in Model Organisms Aging 0 works
- 8 Flexible and Reconfigurable Manufacturing Systems Industrial and Manufacturing Engineering 0 works
- 9 Microfluidic and Bio-sensing Technologies Biomedical Engineering 0 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Michalski Huettermann and Partner's research output changed?
Output in 2018–2022 was 54% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Düsseldorf
- Heinrich Heine University Düsseldorf
- Düsseldorf University Hospital
- Max-Planck-Institut für Nachhaltige Materialien
- Hochschule Düsseldorf University of Applied Sciences
- Deutsches Diabetes-Zentrum e.V.
- Henkel (Germany)
- Nippon Steel (Germany)
- Mitsui Chemicals (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.